Nursing Shortage to Worsen Over Next 2 Decades

Publication
Article
OncologyONCOLOGY Vol 16 No 12
Volume 16
Issue 12

Over the next 2 decades, we will see an increasing shortage of nurses if current trends continue, according to a report by the Health Resources and Services Administration. The report points to a worsening shortfall as nurses retire and too few new

Over the next 2 decades, we will see an increasing shortage of nurses if current trends continue, according to a report by the Health Resources and Services Administration. The report points to a worsening shortfall as nurses retire and too few new people enter the field. In the year 2000, there were an estimated 1.89 million registered nurses in the United States, while the demand for nurses was 2 million—a gap of 6%.

The report forecasts that the shortage will double by 2010and triple by 2015. Trends indicate a 40% increase in demand vs a 6% increase inthe numbers of RNs over the period of 2000 to 2020. Demand is expected to growat an annual rate of 1.7%, but the projected growth in supply is expected topeak at 10% by 2011 and then decline. Moreover, the nursing shortage is notevenly distributed across the 50 states. In 2000, 30 states had a shortage ofnurses, but the report projects that by 2020, 44 states and the District ofColumbia will have nursing shortfalls.

To help address the issue, Congress recently approved and President Bushsigned the Nurse Reinvestment Act, which calls for loans, scholarships, andgrants for students, along with a public service campaign promoting nursingcareers. The American Association of Colleges of Nursing and the American NursesAssociation applaud the legislation. However, funding for the act has not yetbeen approved.

Recent Videos
Historical standards for H3 K27M-mutant diffuse midline glioma treatment may harm healthy central nervous system cells, according to Ashley L. Sumrall, MD.
2 experts are featured in this series.
1 expert is featured in this series.
2 experts are featured in this series.
Dordaviprone was recommended at a dose of 625 mg orally once weekly for adults, and the recommended dosage is based on body weight for pediatric patients.
Extended follow-up for individuals with H3 K27M-mutated diffuse midline glioma may help explain the duration of response across patient subgroups.
Geraldine O’Sullivan Coyne, MD, MRCPI, PhD, described the excitement of seeing novel molecules like antibody drug conjugates become more prominent.